GMR IPO: emergency ambulance service provider goes public
The company listed on the NYSE and raised $478.7 billion in funding

GMR specializes in emergency medical care / Photo: GMR
Preliminary trading in shares of GMR Solutions, a provider of emergency medical services, has begun on the Freedom customer trading system. The company is a heavyweight in emergency medicine and operates in about 1,400 U.S. counties - nearly half of the total, Reuters emphasizes. GMR Solutions securities will appear on the NYSE under the ticker GMRS.US later on Ma. 13.
Details
GMR, also known as Global Medical Response, raised $478.7 million in an IPO. The company placed 31.9 million shares at $15 per paper - well below the previously announced price range ($22-25). Based on the results of the IPO, the value of the entire company can be estimated at $3.35 billion, writes Reuters.
Global Medical Response initially expected to raise up to $797.9 million in the IPO, but then lowered its expectations, Reuters noted.
GMR's listing was arranged by JPMorgan, KKR, BofA Securities, Barclays, Goldman Sachs, Citigroup, Evercore ISI, Morgan Stanley and UBS Investment Bank.
What the company is notable for
GMR, headquartered in Lewisville, Texas, was formed in 2018 when investment firm KKR merged air ambulance operator Air Medical and ground ambulance service American Medical Response. KKR had previously acquired Air Medical from Bain Capital for $2 billion and bought American Medical Response from Envision Healthcare for $2.4 billion, Reuters reported.
KKR currently owns about 89% of GMR, according to GMR's prospectus filed with the U.S. Securities and Exchange Commission (SEC). KKR will retain at least 77% of the company's voting shares after the IPO, Morning Star points out. A significant portion of the money raised by the listing will be used to repurchase about $479 million in class B preferred shares from KKR. It remains unclear how much of the money will actually be used to repay debt and how much will be used to pay investors, IPO specialist Donovan Jones emphasizes on Seeking Alpha.
GMR specializes in emergency medical services and out-of-hospital care in the United States and abroad. The company organizes on-site medical support by professional teams and coordinates the transportation of patients by ground and air.
In 2025, the company's revenues totaled $5.74 billion, showing a 4% year-on-year decline, GMR said in its prospectus. At the same time, operating income grew 22% to $751.6 million, while net income jumped 910% to $206.2 million.
What the analysts are saying
At the current offering price, the stock's growth potential is 10.7%, Freedom Finance analyst Alem Bektemirov said. According to him, the main risks for the company's business are competition, with GMR exposed to a decline in revenues in case of a shift in the composition of payers from commercial structures to government programs or uninsured patients.
GMR's financial health raises questions for analysts, says analyst Donovan Jones in a commentary on Seeking Alpha. Despite the improvement in net income, the business exhibits traits typical of companies managed by private equity funds: high debt and aggressive cost-cutting before going public.
Jones notes that the increase in profits in 2025 is not due to business growth, but to a sharp decline in the "external services expenses" item. According to him, analysts fear that this may be "pre-sales preparation", and such savings rates will be difficult to maintain in the future, specifies Seeking Alpha.
Total debt liabilities amount to $6.8 bln, of which about $5 bln is long-term debt, Jones adds. The ratio of net debt to EBITDA is 4.1, which is high for a company with a high share of personnel costs, emphasizes the analyst.
GMR is now shifting from extensive growth to "defensive positioning," Jones points out. The company is exiting some unprofitable contracts and markets in an effort to increase density and dispatch efficiency in current regions.
GMR has about 10% of the market for all 911 calls in the US and 37% of air ambulance calls. The main risk here is dependence on payments from insurance companies and government programs (Medicare/Medicaid), summarizes Jones. The preliminary outlook for the company's IPO remains negative, he says. The main constraints are declining total revenues and a huge debt load, with the current margin improvement being achieved solely through aggressive cost compression rather than organic business growth.
___________________
Freedom clients will be able to get access to GMR shares before the opening of the main exchange session. Trading will begin in the early pre-market format 2-3 hours before the opening of the US exchanges (from 15:30-16:30 Astana time). To participate click on ticker GMRS.US.
This article was AI-translated and verified by a human editor




